Scripta Insights has announced the addition of David Kershaw to their executive leadership team as their new chief technology officer (CTO). The company has experienced significant growth in the past year, with the release of their enhanced member app and a partnership with Cost Plus Drugs, owned by Mark Cuban.
In his new role, Kershaw will be responsible for driving Scripta’s technological vision and strategy. He will also lead innovation initiatives, oversee the engineering and IT teams, and work towards providing groundbreaking solutions such as Scripta’s Med Mapper and member app, an Rx comparison-shopping tool.
Eric Levin, CEO of Scripta Insights, expressed his excitement about Kershaw joining the team. He highlighted Kershaw’s successful track record and passion for improving the quality of life for everyone. Levin believes that Kershaw’s expertise will be invaluable as Scripta continues to scale and innovate in the pharmacy benefits landscape.
With over 20 years of experience in leading engineering teams across various industries, including healthcare and biotech, Kershaw brings a wealth of knowledge to his new role. He previously held leadership positions at companies like Tactiq, DataKitchen, and the Broad Institute of MIT and Harvard. Kershaw holds a Master’s degree in Industrial Policy from Harvard University.
Scripta Insights is a venture-backed digital health company that specializes in developing pharmacy navigation solutions for self-insured employers, health plans, and their members. The company is dedicated to transforming the pharmacy benefits landscape and helping clients and their members save on prescription costs through innovative technology solutions.
